1. Medtech Insight

Minute Insight: Abbott Teams Up With WeightWatchers In Diabetes Management

 
• By Barnaby Pickering

The companies will link Abbott’s blood glucose monitoring devices to WeightWatchers’ smartphone apps and weight loss program.

Minute Insight
• Source: Informa/Alamy

Abbott will integrate its FreeStyle Libre range of continuous glucose monitoring devices with WeightWatchers’ diabetes-tailored weight loss program to create a version of WeightWatchers’ smartphone app for obese diabetics that will provide the information they need to make good health decisions and control their blood glucose levels.

WeightWatchers CEO Sima Sistani said the partnership with Abbott will "make it possible for people with diabetes to reach their weight and healthy-living goals while enjoying the foods they love...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.